Beta-lactam hypersensitivity: not always what it seems
© Andrade et al; licensee BioMed Central Ltd. 2015
Published: 8 April 2015
Beta-lactam allergy is a frequent cause of visit to the allergist office. The aim of this study was to describe the characteristics of children with a suspected beta-lactam hypersensitivity reaction in a specialized drug allergy unit.
Retrospective analysis based on medical records using an adapted ENDA questionnaire of patients under 18 years old from July 2011 to June 2014.
One hundred and four children were evaluated with a suspected drug allergy history, with 28% reporting reactions to beta-lactam antibiotics. The mean age was 6.2 years and 52% were female. Cutaneous symptoms were the most frequent reported (89%), followed by respiratory (45%). Most of them had maculopapular exanthema (52%). Urticaria and/or angioedema were seen in 34% of patients. The majority of the reactions were mild/moderate (93%), occurring in the first 24 hours after drug intake (77%), and 48% presented associated fever. The suspected drugs were: amoxicilin (59%), cefalexin (16%), penicilin and ceftriaxone (8% each). Patients went to an Emergency Unit in 97% of the reactions and treated with anti-histaminic drugs and corticosteroids in 40% and 30% respectively. Epinephrine was used in just one patient. In almost half of the patients the clinical history was not consistent enough to submit them to an extensive investigation. Of those who were investigated, skin tests were performed in 48% (57% prick tests and 43% intradermal tests). Positive test was seen in only one patient (cefazolin). Drug provocation tests with amoxicilin were performed in 57% of patients and none was positive.
The prevalence of children with a beta-lactam hypersensitivity history is high, but a few cases are confirmed as allergic after an adequate investigation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.